nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—CA6—submandibular gland—pharynx cancer	0.203	0.243	CbGeAlD
Celecoxib—CA6—saliva—pharynx cancer	0.073	0.0875	CbGeAlD
Celecoxib—CA6—ear—pharynx cancer	0.0667	0.08	CbGeAlD
Celecoxib—ORM1—saliva—pharynx cancer	0.0388	0.0466	CbGeAlD
Celecoxib—CA6—mouth—pharynx cancer	0.0276	0.0331	CbGeAlD
Celecoxib—MAPK14—mouth—pharynx cancer	0.0244	0.0293	CbGeAlD
Celecoxib—MAPK14—neck—pharynx cancer	0.0209	0.025	CbGeAlD
Celecoxib—PDPK1—lymphoid tissue—pharynx cancer	0.0204	0.0245	CbGeAlD
Celecoxib—CA6—parotid gland—pharynx cancer	0.0192	0.023	CbGeAlD
Celecoxib—PDPK1—spinal cord—pharynx cancer	0.0185	0.0222	CbGeAlD
Celecoxib—CA6—saliva-secreting gland—pharynx cancer	0.0184	0.0221	CbGeAlD
Celecoxib—PDPK1—head—pharynx cancer	0.0165	0.0197	CbGeAlD
Celecoxib—MAPK14—brainstem—pharynx cancer	0.0159	0.0191	CbGeAlD
Celecoxib—MAPK14—epithelium—pharynx cancer	0.0142	0.017	CbGeAlD
Celecoxib—PDPK1—lymph node—pharynx cancer	0.0115	0.0138	CbGeAlD
Celecoxib—MAPK14—lymphoid tissue—pharynx cancer	0.0109	0.0131	CbGeAlD
Celecoxib—CA6—head—pharynx cancer	0.00996	0.0119	CbGeAlD
Celecoxib—MAPK14—spinal cord—pharynx cancer	0.00991	0.0119	CbGeAlD
Celecoxib—CA4—neck—pharynx cancer	0.00979	0.0117	CbGeAlD
Celecoxib—CA14—spinal cord—pharynx cancer	0.00964	0.0116	CbGeAlD
Celecoxib—CA12—trachea—pharynx cancer	0.00952	0.0114	CbGeAlD
Celecoxib—CA2—mouth—pharynx cancer	0.0095	0.0114	CbGeAlD
Celecoxib—MAPK14—head—pharynx cancer	0.00881	0.0106	CbGeAlD
Celecoxib—CA2—neck—pharynx cancer	0.00812	0.00974	CbGeAlD
Celecoxib—CA4—parotid gland—pharynx cancer	0.00798	0.00957	CbGeAlD
Celecoxib—CA4—saliva-secreting gland—pharynx cancer	0.00764	0.00916	CbGeAlD
Celecoxib—CA4—brainstem—pharynx cancer	0.00748	0.00898	CbGeAlD
Celecoxib—CYP2D6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.00729	0.0438	CbGpPWpGaD
Celecoxib—PTGS2—mouth—pharynx cancer	0.00701	0.00841	CbGeAlD
Celecoxib—CA12—head—pharynx cancer	0.00668	0.00801	CbGeAlD
Celecoxib—CA2—parotid gland—pharynx cancer	0.00661	0.00793	CbGeAlD
Celecoxib—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.00639	0.0384	CbGpPWpGaD
Celecoxib—CA2—saliva-secreting gland—pharynx cancer	0.00634	0.0076	CbGeAlD
Celecoxib—CA2—brainstem—pharynx cancer	0.00621	0.00744	CbGeAlD
Celecoxib—MAPK14—lymph node—pharynx cancer	0.00617	0.0074	CbGeAlD
Celecoxib—CA5B—head—pharynx cancer	0.00599	0.00719	CbGeAlD
Celecoxib—ORM1—spinal cord—pharynx cancer	0.00596	0.00715	CbGeAlD
Celecoxib—CA4—trachea—pharynx cancer	0.00589	0.00707	CbGeAlD
Celecoxib—CA2—epithelium—pharynx cancer	0.00553	0.00663	CbGeAlD
Celecoxib—CA2—trachea—pharynx cancer	0.00489	0.00586	CbGeAlD
Celecoxib—PDPK1—BCR signaling pathway—CD79A—pharynx cancer	0.0048	0.0289	CbGpPWpGaD
Celecoxib—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.00477	0.0287	CbGpPWpGaD
Celecoxib—CA4—spinal cord—pharynx cancer	0.00465	0.00558	CbGeAlD
Celecoxib—ABCC4—head—pharynx cancer	0.0045	0.0054	CbGeAlD
Celecoxib—CA2—lymphoid tissue—pharynx cancer	0.00426	0.00511	CbGeAlD
Celecoxib—CA5B—lymph node—pharynx cancer	0.0042	0.00503	CbGeAlD
Celecoxib—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.00418	0.0251	CbGpPWpGaD
Celecoxib—CA4—head—pharynx cancer	0.00414	0.00496	CbGeAlD
Celecoxib—PTGS2—epithelium—pharynx cancer	0.00408	0.00489	CbGeAlD
Celecoxib—CYP2D6—brainstem—pharynx cancer	0.00394	0.00473	CbGeAlD
Celecoxib—CA2—spinal cord—pharynx cancer	0.00386	0.00463	CbGeAlD
Celecoxib—ORM1—lymph node—pharynx cancer	0.00371	0.00445	CbGeAlD
Celecoxib—PTGS2—trachea—pharynx cancer	0.00361	0.00433	CbGeAlD
Celecoxib—PDPK1—B Cell Receptor Signaling Pathway—CD79A—pharynx cancer	0.00357	0.0215	CbGpPWpGaD
Celecoxib—CA2—head—pharynx cancer	0.00343	0.00411	CbGeAlD
Celecoxib—ABCC4—NRF2 pathway—ADH7—pharynx cancer	0.00333	0.02	CbGpPWpGaD
Celecoxib—PDPK1—Trk receptor signaling mediated by PI3K and PLC-gamma—CCND1—pharynx cancer	0.00328	0.0197	CbGpPWpGaD
Celecoxib—ALB—lymph node—pharynx cancer	0.00325	0.0039	CbGeAlD
Celecoxib—PDPK1—FGF signaling pathway—CDH1—pharynx cancer	0.00318	0.0191	CbGpPWpGaD
Celecoxib—ABCC4—lymph node—pharynx cancer	0.00315	0.00378	CbGeAlD
Celecoxib—PTGS2—lymphoid tissue—pharynx cancer	0.00314	0.00377	CbGeAlD
Celecoxib—CA4—lymph node—pharynx cancer	0.0029	0.00347	CbGeAlD
Celecoxib—PTGS2—spinal cord—pharynx cancer	0.00285	0.00342	CbGeAlD
Celecoxib—PTGS2—head—pharynx cancer	0.00253	0.00304	CbGeAlD
Celecoxib—MAPK14—BCR signaling pathway—CD79A—pharynx cancer	0.00249	0.015	CbGpPWpGaD
Celecoxib—CA2—lymph node—pharynx cancer	0.0024	0.00288	CbGeAlD
Celecoxib—PDPK1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—CDH1—pharynx cancer	0.00232	0.014	CbGpPWpGaD
Celecoxib—CYP2D6—head—pharynx cancer	0.00218	0.00261	CbGeAlD
Celecoxib—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00205	0.0123	CbGpPWpGaD
Celecoxib—PDPK1—B Cell Activation—CD79A—pharynx cancer	0.00204	0.0123	CbGpPWpGaD
Celecoxib—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00204	0.0122	CbGpPWpGaD
Celecoxib—MAPK14—B Cell Receptor Signaling Pathway—CD79A—pharynx cancer	0.00186	0.0112	CbGpPWpGaD
Celecoxib—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0018	0.0108	CbGpPWpGaD
Celecoxib—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00178	0.0107	CbGpPWpGaD
Celecoxib—PTGS2—lymph node—pharynx cancer	0.00177	0.00213	CbGeAlD
Celecoxib—PDPK1—Signaling Pathways in Glioblastoma—CCND1—pharynx cancer	0.0017	0.0102	CbGpPWpGaD
Celecoxib—MAPK14—RAC1 signaling pathway—CDH1—pharynx cancer	0.00165	0.00993	CbGpPWpGaD
Celecoxib—MAPK14—FGF signaling pathway—CDH1—pharynx cancer	0.00165	0.00993	CbGpPWpGaD
Celecoxib—MAPK14—Nanoparticle-mediated activation of receptor signaling—EGFR—pharynx cancer	0.00163	0.00982	CbGpPWpGaD
Celecoxib—CA14—Metabolism—CNDP2—pharynx cancer	0.00147	0.00887	CbGpPWpGaD
Celecoxib—CA6—Metabolism—CNDP2—pharynx cancer	0.00144	0.00864	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—CNDP2—pharynx cancer	0.00144	0.00864	CbGpPWpGaD
Celecoxib—ABCC4—Fluoropyrimidine Activity—TP53—pharynx cancer	0.00137	0.00826	CbGpPWpGaD
Celecoxib—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00134	0.00807	CbGpPWpGaD
Celecoxib—MAPK14—CDC42 signaling events—CDH1—pharynx cancer	0.00134	0.00807	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—CNDP2—pharynx cancer	0.00134	0.00807	CbGpPWpGaD
Celecoxib—CA14—Metabolism—ADH7—pharynx cancer	0.00133	0.00802	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways in Glioblastoma—EGFR—pharynx cancer	0.00133	0.008	CbGpPWpGaD
Celecoxib—CA6—Metabolism—ADH7—pharynx cancer	0.0013	0.00782	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—ADH7—pharynx cancer	0.0013	0.00782	CbGpPWpGaD
Celecoxib—PDPK1—Constitutive PI3K/AKT Signaling in Cancer—EGFR—pharynx cancer	0.00128	0.0077	CbGpPWpGaD
Celecoxib—CA12—Metabolism—CNDP2—pharynx cancer	0.00124	0.00747	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—ADH7—pharynx cancer	0.00121	0.0073	CbGpPWpGaD
Celecoxib—CYP2D6—Biological oxidations—CNDP2—pharynx cancer	0.00121	0.00725	CbGpPWpGaD
Celecoxib—CYP2C9—Biological oxidations—CNDP2—pharynx cancer	0.0012	0.00719	CbGpPWpGaD
Celecoxib—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00118	0.00708	CbGpPWpGaD
Celecoxib—CA14—Metabolism—ADH1B—pharynx cancer	0.00117	0.00703	CbGpPWpGaD
Celecoxib—PDPK1—PI-3K cascade—EGFR—pharynx cancer	0.00115	0.00694	CbGpPWpGaD
Celecoxib—MAPK14—Signaling mediated by p38-alpha and p38-beta—TP53—pharynx cancer	0.00115	0.0069	CbGpPWpGaD
Celecoxib—MAPK14—ATF-2 transcription factor network—CCND1—pharynx cancer	0.00115	0.0069	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—ADH1B—pharynx cancer	0.00114	0.00685	CbGpPWpGaD
Celecoxib—CA6—Metabolism—ADH1B—pharynx cancer	0.00114	0.00685	CbGpPWpGaD
Celecoxib—PDPK1—PI3K/AKT activation—EGFR—pharynx cancer	0.00113	0.00677	CbGpPWpGaD
Celecoxib—CA12—Metabolism—ADH7—pharynx cancer	0.00112	0.00676	CbGpPWpGaD
Celecoxib—CA14—Metabolism—B4GALT5—pharynx cancer	0.00112	0.00672	CbGpPWpGaD
Celecoxib—PDPK1—GAB1 signalosome—EGFR—pharynx cancer	0.00112	0.00672	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways in Glioblastoma—TP53—pharynx cancer	0.00112	0.00672	CbGpPWpGaD
Celecoxib—PDPK1—ErbB1 downstream signaling—EGFR—pharynx cancer	0.00109	0.00657	CbGpPWpGaD
Celecoxib—PDPK1—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—pharynx cancer	0.00109	0.00657	CbGpPWpGaD
Celecoxib—CYP2D6—Biological oxidations—ADH7—pharynx cancer	0.00109	0.00656	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—B4GALT5—pharynx cancer	0.00109	0.00655	CbGpPWpGaD
Celecoxib—CA6—Metabolism—B4GALT5—pharynx cancer	0.00109	0.00655	CbGpPWpGaD
Celecoxib—CYP2C9—Biological oxidations—ADH7—pharynx cancer	0.00108	0.0065	CbGpPWpGaD
Celecoxib—MAPK14—Amyotrophic lateral sclerosis (ALS)—TP53—pharynx cancer	0.00107	0.00646	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—ADH1B—pharynx cancer	0.00106	0.0064	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of retinoblastoma protein—CCND1—pharynx cancer	0.00105	0.00631	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—B4GALT5—pharynx cancer	0.00102	0.00611	CbGpPWpGaD
Celecoxib—CA4—Metabolism—CNDP2—pharynx cancer	0.000991	0.00596	CbGpPWpGaD
Celecoxib—CA12—Metabolism—ADH1B—pharynx cancer	0.000986	0.00593	CbGpPWpGaD
Celecoxib—CYP2D6—Biological oxidations—ADH1B—pharynx cancer	0.000956	0.00575	CbGpPWpGaD
Celecoxib—CA2—Metabolism—CNDP2—pharynx cancer	0.00095	0.00571	CbGpPWpGaD
Celecoxib—CYP2C9—Biological oxidations—ADH1B—pharynx cancer	0.000948	0.0057	CbGpPWpGaD
Celecoxib—MAPK14—Leptin signaling pathway—CCND1—pharynx cancer	0.000947	0.00569	CbGpPWpGaD
Celecoxib—CA12—Metabolism—B4GALT5—pharynx cancer	0.000942	0.00566	CbGpPWpGaD
Celecoxib—MAPK14—Thromboxane A2 receptor signaling—EGFR—pharynx cancer	0.000938	0.00564	CbGpPWpGaD
Celecoxib—CA4—Metabolism—ADH7—pharynx cancer	0.000896	0.00539	CbGpPWpGaD
Celecoxib—PDPK1—Focal Adhesion—CCND1—pharynx cancer	0.000866	0.00521	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by SCF-KIT—EGFR—pharynx cancer	0.000862	0.00519	CbGpPWpGaD
Celecoxib—CA2—Metabolism—ADH7—pharynx cancer	0.000859	0.00517	CbGpPWpGaD
Celecoxib—PDPK1—Disease—B4GALT5—pharynx cancer	0.000842	0.00506	CbGpPWpGaD
Celecoxib—PDPK1—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.000825	0.00496	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—CD79A—pharynx cancer	0.000823	0.00495	CbGpPWpGaD
Celecoxib—MAPK14—AGE/RAGE pathway—EGFR—pharynx cancer	0.000823	0.00495	CbGpPWpGaD
Celecoxib—MAPK14—Cell-Cell communication—CDH1—pharynx cancer	0.000818	0.00492	CbGpPWpGaD
Celecoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—EGFR—pharynx cancer	0.000813	0.00489	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by ERBB4—EGFR—pharynx cancer	0.000812	0.00488	CbGpPWpGaD
Celecoxib—CA9—Metabolism—CNDP2—pharynx cancer	0.000801	0.00482	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	0.000788	0.00474	CbGpPWpGaD
Celecoxib—CA4—Metabolism—ADH1B—pharynx cancer	0.000786	0.00473	CbGpPWpGaD
Celecoxib—PDPK1—Downstream signal transduction—EGFR—pharynx cancer	0.000776	0.00466	CbGpPWpGaD
Celecoxib—PDPK1—EGF/EGFR Signaling Pathway—EGFR—pharynx cancer	0.000772	0.00464	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by FGFR—EGFR—pharynx cancer	0.000772	0.00464	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by ERBB2—EGFR—pharynx cancer	0.000768	0.00462	CbGpPWpGaD
Celecoxib—PDPK1—DAP12 signaling—EGFR—pharynx cancer	0.000764	0.0046	CbGpPWpGaD
Celecoxib—MAPK14—p53 pathway—TP53—pharynx cancer	0.000755	0.00454	CbGpPWpGaD
Celecoxib—CA2—Metabolism—ADH1B—pharynx cancer	0.000754	0.00453	CbGpPWpGaD
Celecoxib—PDPK1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.000753	0.00453	CbGpPWpGaD
Celecoxib—CA4—Metabolism—B4GALT5—pharynx cancer	0.000751	0.00452	CbGpPWpGaD
Celecoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—pharynx cancer	0.000733	0.00441	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ADH7—pharynx cancer	0.000724	0.00436	CbGpPWpGaD
Celecoxib—CA2—Metabolism—B4GALT5—pharynx cancer	0.00072	0.00433	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000719	0.00432	CbGpPWpGaD
Celecoxib—PDPK1—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000719	0.00432	CbGpPWpGaD
Celecoxib—PDPK1—DAP12 interactions—EGFR—pharynx cancer	0.000719	0.00432	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—ADH7—pharynx cancer	0.000713	0.00429	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by EGFR—EGFR—pharynx cancer	0.000713	0.00428	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000706	0.00425	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by PDGF—EGFR—pharynx cancer	0.000703	0.00423	CbGpPWpGaD
Celecoxib—PTGS2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.000701	0.00422	CbGpPWpGaD
Celecoxib—MAPK14—Oncostatin M Signaling Pathway—TP53—pharynx cancer	0.000699	0.0042	CbGpPWpGaD
Celecoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—TP53—pharynx cancer	0.000682	0.0041	CbGpPWpGaD
Celecoxib—PDPK1—Focal Adhesion—EGFR—pharynx cancer	0.000679	0.00409	CbGpPWpGaD
Celecoxib—PDPK1—B Cell Activation—EGFR—pharynx cancer	0.000665	0.004	CbGpPWpGaD
Celecoxib—PDPK1—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000637	0.00383	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ADH1B—pharynx cancer	0.000635	0.00382	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.000625	0.00376	CbGpPWpGaD
Celecoxib—CA9—Metabolism—B4GALT5—pharynx cancer	0.000607	0.00365	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—CCND1—pharynx cancer	0.000602	0.00362	CbGpPWpGaD
Celecoxib—MAPK14—Glucocorticoid receptor regulatory network—TP53—pharynx cancer	0.000581	0.00349	CbGpPWpGaD
Celecoxib—PTGS2—C-MYB transcription factor network—CCND1—pharynx cancer	0.000552	0.00332	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CD79A—pharynx cancer	0.000499	0.003	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by NGF—EGFR—pharynx cancer	0.00049	0.00295	CbGpPWpGaD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—TP53—pharynx cancer	0.000476	0.00286	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—CDH1—pharynx cancer	0.000459	0.00276	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000448	0.00269	CbGpPWpGaD
Celecoxib—MAPK14—Oxidative Stress Induced Senescence—TP53—pharynx cancer	0.000431	0.00259	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—CCND1—pharynx cancer	0.000421	0.00253	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—EGFR—pharynx cancer	0.000401	0.00241	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—TP53—pharynx cancer	0.000397	0.00239	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—EGFR—pharynx cancer	0.00039	0.00234	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—TP53—pharynx cancer	0.000378	0.00227	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—TP53—pharynx cancer	0.000357	0.00215	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000352	0.00211	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000331	0.00199	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—EGFR—pharynx cancer	0.00033	0.00199	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TP53—pharynx cancer	0.000327	0.00197	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CNDP2—pharynx cancer	0.000309	0.00186	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—TP53—pharynx cancer	0.000301	0.00181	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000295	0.00178	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000286	0.00172	CbGpPWpGaD
Celecoxib—PTGS2—Disease—B4GALT5—pharynx cancer	0.000279	0.00168	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—EGFR—pharynx cancer	0.000279	0.00168	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ADH7—pharynx cancer	0.000279	0.00168	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CDH1—pharynx cancer	0.000278	0.00167	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TP53—pharynx cancer	0.000277	0.00167	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—EGFR—pharynx cancer	0.000268	0.00161	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TP53—pharynx cancer	0.000261	0.00157	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD79A—pharynx cancer	0.00026	0.00156	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—EGFR—pharynx cancer	0.000255	0.00153	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CNDP2—pharynx cancer	0.00025	0.0015	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ADH1B—pharynx cancer	0.000245	0.00147	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—B4GALT5—pharynx cancer	0.000234	0.00141	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—TP53—pharynx cancer	0.000228	0.00137	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ADH7—pharynx cancer	0.000226	0.00136	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000225	0.00135	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CNDP2—pharynx cancer	0.000206	0.00124	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CNDP2—pharynx cancer	0.000204	0.00123	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ADH1B—pharynx cancer	0.000198	0.00119	CbGpPWpGaD
Celecoxib—ALB—Metabolism—B4GALT5—pharynx cancer	0.000189	0.00114	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000189	0.00113	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ADH7—pharynx cancer	0.000187	0.00112	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ADH7—pharynx cancer	0.000185	0.00111	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—EGFR—pharynx cancer	0.000178	0.00107	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—EGFR—pharynx cancer	0.000164	0.000988	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ADH1B—pharynx cancer	0.000164	0.000984	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—EGFR—pharynx cancer	0.000163	0.000978	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ADH1B—pharynx cancer	0.000162	0.000975	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—B4GALT5—pharynx cancer	0.000156	0.00094	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—B4GALT5—pharynx cancer	0.000155	0.000932	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TP53—pharynx cancer	0.000155	0.00093	CbGpPWpGaD
Celecoxib—PDPK1—Disease—EGFR—pharynx cancer	0.00015	0.000903	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—EGFR—pharynx cancer	0.000145	0.000873	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CDH1—pharynx cancer	0.000145	0.000869	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TP53—pharynx cancer	0.000135	0.000814	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.000135	0.000811	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CCND1—pharynx cancer	0.000134	0.000806	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ADH7—pharynx cancer	0.000122	0.000733	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ADH1B—pharynx cancer	0.000107	0.000643	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EGFR—pharynx cancer	0.000105	0.000633	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—B4GALT5—pharynx cancer	0.000102	0.000615	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—pharynx cancer	8.83e-05	0.000531	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—EGFR—pharynx cancer	8.45e-05	0.000508	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—pharynx cancer	7e-05	0.000421	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCND1—pharynx cancer	6.97e-05	0.000419	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EGFR—pharynx cancer	5.47e-05	0.000329	CbGpPWpGaD
Celecoxib—PTGS2—Disease—EGFR—pharynx cancer	4.99e-05	0.0003	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—pharynx cancer	4.59e-05	0.000276	CbGpPWpGaD
